Financial News

Financial Report: PAREXEL

Service revenues up 4% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL 2Q Revenues: $604.2 million (+5%) 2Q Earnings: $39.4 million (+2%) YTD Revenues: $1.2 billion (+4%) YTD Earnings: $64.3 million (-15%) Comments: Service revenues were $518.5 million in the quarter, up 4%. Clinical Research Services (CRS) revenue was $407.1 million, PAREXEL Consulting (PC) sales were $41.4 million, and PAREXEL Informatics sales were $70.0 million. A restructuring charge of $10.4 million was recorded in the quarter related to PAREXEL’s ongoing Margin Acceler...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters